Information about Myfortic (Mycophenolic Acid)
Myfortic is a medication that contains mycophenolic acid, an immunosuppressant used primarily to prevent organ rejection in patients who have undergone kidney transplantation. It works by inhibiting lymphocyte proliferation, thereby suppressing the immune response.
Product Highlights
- Mycophenolic acid selectively inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme crucial for lymphocyte proliferation.
- To prevent organ rejection in those who have received a kidney transplant.
- Can be used alongside other immunosuppressants.
Key Ingredient
Key Benefits
- Reduces the risk of organ rejection, enhancing transplant success rates.
- Typically well-tolerated, with a manageable side effect profile.
- Can improve long-term outcomes for transplant recipients when used as part of a comprehensive immunosuppressive regimen.
Direction of Use
- Take as directed by a healthcare professional, usually twice daily.
- Should be taken consistently, either with or without food, but maintaining the same dietary conditions each day is important for optimal absorption.
Safety Concerns
- Common side effects may include gastrointestinal symptoms (such as diarrhea and nausea), headache, and increased risk of infections.
- Serious side effects can include blood disorders, liver toxicity, and gastrointestinal complications.
Avoid Myfortic (Mycophenolic Acid) If
- You have a known hypersensitivity to mycophenolic acid or any of its components.
- You are pregnant or planning to become pregnant, as it can cause harm to the fetus.
- You have active infections or severe immunodeficiency without appropriate medical supervision.
